Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C

doi:10.3748/wjg.v11.i12.1769

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2536)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

244

HTML

2040

Figures (1-3)

132

Tables (1-1)

120

Sum=2536

Mar 28, 2005 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 28, 2005; 11(12): 1769-1774
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1769

Full Size Figure Download Figure

Figure 1 Depression scores on the Hospital Anxiety and Depression Scale (HADS) during interferon therapy (total results and stratification for therapy subgroups; mean±SE of the mean).

Citation: Kraus MR, Schäfer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1769-1774
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1769.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1769